Feeds:
Posts
Comments

Archive for the ‘TREATMENT’ Category

PROSTABLOG NZ: My last PSA test recently showed it continues to be undetectable, some 20 months after my surgery in March, 2009.

But I’m not getting cocky just yet (forgive the pun).

From what I’ve read about prostate cancer treatment, if the cancer bug has got out of the organ during/after a prostatectomy, there’s a good chance the first signs will come two years after the operation.

My two-year anniversary comes up in a couple of months – so wish me luck.

It’s interesting how long it takes to fully recover from the surgery’s effects.

My scar is virtually gone and I’ve felt fit for ages.

There’s no incontinence. I haven’t done the pelvic floor exercises for more than a year, but there’s never any problem with not being able to hold it in, even when I’m busting.

Not that I put myself in the busting mode if I can avoid it.

So, hey, no regrets and no real worries. I’m bloody lucky.

Well, there is one worry – the number of friends and people I know who have been diagnosed. Talk about an epidemic.

And I wonder if the NZ Parliamentary Health Select Committee will ever get round to reporting back on its prostate cancer inquiry…

Read Full Post »

Publicly funded chemotherapy clinics in NZ have increased 25% in two years, to just over 57,000 outpatient sessions in public hospitals in the 2009/10 year, says Health Minister Tony Ryall. READ MORE>

Read Full Post »

HEALTH NEWS TODAY: When combined with the erectile-dysfunction drug Viagra, a long-used chemotherapy drug called doxorubicin may be even more effective as a treatment for prostate cancer, according to a new study. READ MORE>

Read Full Post »

WASHINGTON EXAMINER.COM:  Here’s a well-written article on the current US debate about how much a life is worth – more specifically, how much the government Medicare scheme and health insurers pay out for cancer drugs that prolong life for a few months. READ MORE>

Read Full Post »

THE ENGINEER: A web-based software system that could help health professionals to manage the treatment of prostate cancer has been developed in the East Midlands. READ MORE>
The system will mean that patients with less complex conditions will not have to make repeat trips to hospital, while consultants will have more time to focus on and treat the most serious urological disorders.

Read Full Post »

BLOOMBERG BUSINESSWEEK: A US company will next month report the results of its study of abiraterone acetate plus prednisone for the treatment of patients with metastatic advanced prostate cancer, also called castration-resistant prostate cancer. READ MORE>

Read Full Post »

MARKETWIRE:  The approval of Dendreon’s prostate cancer vaccine Provenge in April was a boon for a nascent cancer vaccine industry that had suffered several setbacks, and should lead to an influx of market opportunities and a surge in regulatory activity. READ MORE>

Read Full Post »

Older Posts »

Follow

Get every new post delivered to your Inbox.